FIELD: medicine, laboratory diagnostics.
SUBSTANCE: it is necessary to study saliva due to carrying out immunoenzymatic assay by applying mycobacterial antigen specifically binding with human secretory immunoglobulin A only, and specific monoclonal antibodies directed against human secretory immunoglobulin A. The present method is considered to be of high efficiency, noninvasive, simple in application, of high information value, specificity and sensitivity to tuberculosis.
EFFECT: higher accuracy of diagnostics.
3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING TUBERCULOSIS | 2022 |
|
RU2794855C1 |
| METHOD OF POLLINOSIS DIAGNOSTICS "IN VITRO" IN SALIVA | 2007 |
|
RU2340895C1 |
| DIAGNOSTIC TECHNIQUE FOR MYCOBACTERIUM TUBERCULOSIS | 2015 |
|
RU2594063C1 |
| METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
| METHOD FOR EVALUATING ANTIBACTERIAL IMMUNITY TO DIPHTHERIA | 2001 |
|
RU2197730C2 |
| METHOD FOR DIAGNOSING TUBERCULOSIS AND DIFFERENTIAL DIAGNOSIS OF TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION | 2014 |
|
RU2576833C1 |
| METHOD FOR DETECTING ANTIBODIES TO SARS-CoV-2 IN MIXED SALIVA | 2022 |
|
RU2787171C1 |
| METHOD OF DETERMINING CONTENT OF PROTEOLYSIS PRODUCTS IN BLOOD PLASMA AND DIAGNOSTIC TEST SYSTEM THEREFOR | 2015 |
|
RU2597782C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| RECOMBINANT PLASMID DNA pTB323 CODING HYBRID POLYPEPTIDE CST-DELTAMPT64 WITH PROPERTIES OF SPECIES-SPECIFIC MYCOBACTERIAL ANTIGEN MPT64 (MPB64), RECOMBINANT ESCHERICHIA COLI BACTERIAL STRAIN - PRODUCER OF HYBRID POLYPEPTIDE CST-DELTAMPT64 AND RECOMBINANT POLYPEPTIDE CST-DELTAMPT64 | 2011 |
|
RU2458130C1 |
